Branched vessel endoluminal device

Details for Australian Patent Application No. 2004206815 (hide)

Owner The Cleveland Clinic Foundation

Inventors Greenberg, Roy K.; Skender, Davorin; Foster, James; West, Karl

Agent Spruson & Ferguson

Pub. Number AU-B-2004206815

PCT Pub. Number WO2004/064686

Priority 60/510,636 10.10.03 US; 60/439,923 14.01.03 US; 60/478,107 11.06.03 US

Filing date 13 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 25 October 2007

International Classifications

A61F 2/06 (2006.01) Filters - Blood vessels

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064686 Priority application(s): WO2004/064686

25 October 2007 Application Accepted

  Published as AU-B-2004206815

17 January 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 13 Dec 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

28 February 2008 Standard Patent Sealed

29 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Dec 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206820-Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

2004206812-3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes